Pharma Pulse 5/10/24: Where Is the AI Boom Taking Us? Drug Recalls & more

Drug Recalls: Q&A with Beth Riggio

Cencora’s vice president of product management, global products & solutions Beth Riggio discusses the issues the industry faces with recalls and how it can improve.

Medicare Advantage, Racing Along, Hits Some Speed Bumps

Enrollment has soared, but a relatively modest 2025 rate increase and changes to the Star rating system may lead plans to cut back on with their benefit offerings.

Where Is the AI Boom Taking Us? Business Leaders Disagree on Outlook

The technology’s promises and perils were a central focus of the WSJ’s CEO Council Summit

Anti-Obesity Drugs Global Strategic Business Report 2024-2030

The global market for Anti-Obesity Drugs estimated at US$2.7 Billion in the year 2023, is projected to reach a revised size of US$4.8 Billion by 2030, growing at a CAGR of 8.7% over the analysis period 2023-2030.

AeroSafe Global on LinkedIn:

📢 We're thrilled to be featured in this article by Pharmaceutical Commerce Magazine that addresses the need for pharmaceutical cold chain visibility and sustainability.

We're proud to be leaders in both these areas with our reusable thermal solutions that can be used up to 70x and a visibility platform, Cold Chain Intel, that provides real-time and forecasted shipment location and therapy temperature.

Read about our journey to help companies meet their sustainability goals and make cold chain more reliable to ensure the safe delivery of therapeutics.https://hubs.ly/Q02wGmp10🌱👀💉

#resusablepackaging #pharmacoldchain #visibility #sustainability

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs